Loading...

Alice Yu

Title(s)Recall Faculty, Pediatrics
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
Phone8/2-46--0027
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Predicting toxicity and success of anti-GD2 immunotherapy of neuroblastoma
    NIH/NCI R01CA164132Apr 1, 2012 - Mar 31, 2015
    Role: Principal Investigator
    IMMUNE MONITOR FOR COG TRIAL OF ANTI-GD2 IN NEUROBLASTOMA
    FDA R01FD002319Sep 30, 2003 - May 31, 2010
    Role: Principal Investigator
    CLINICAL TRIAL OF ANTIID VACCINE FOR NEUROBLASTOMA
    NIH/NCI R21CA078806Jul 1, 1998 - Jun 30, 2000
    Role: Principal Investigator
    General Clinical Research Center
    NIH/NCRR M01RR000827Jan 27, 1997 - Nov 30, 2010
    Role: Co-Investigator
    EXPLOITATION OF FREQUENT P16 DELETION IN T-ALL THERAPY
    NIH/NCI R21CA070397Apr 1, 1996 - Mar 31, 1998
    Role: Principal Investigator
    CLINICAL UTILITY OF A NEUROBLASTOMA MONOCLONAL ANTIBODY
    NIH/NCI R01CA040186Sep 1, 1985 - Nov 30, 1988
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Anti-GD2 induced allodynia in rats can be reduced by pretreatment with DFMO. PLoS One. 2020; 15(7):e0236115. Diccianni MB, Kempinska K, Gangoti JA, Yu AL, Sorkin LS. PMID: 32697811.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    2. Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group. J Clin Oncol. 2020 Jul 01; 38(19):2160-2169. Mody R, Yu AL, Naranjo A, Zhang FF, London WB, Shulkin BL, Parisi MT, Servaes SE, Diccianni MB, Hank JA, Felder M, Birstler J, Sondel PM, Asgharzadeh S, Glade-Bender J, Katzenstein H, Maris JM, Park JR, Bagatell R. PMID: 32343642.
      View in: PubMed   Mentions:    Fields:    
    3. A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma. Clin Cancer Res. 2019 11 01; 25(21):6320-6328. Furman WL, Federico SM, McCarville MB, Shulkin BL, Davidoff AM, Krasin MJ, Sahr N, Sykes A, Wu J, Brennan RC, Bishop MW, Helmig S, Stewart E, Navid F, Triplett B, Santana VM, Bahrami A, Anthony G, Yu AL, Hank J, Gillies SD, Sondel PM, Leung WH, Pappo AS. PMID: 31601569.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsCTClinical Trials
    4. GPER-induced signaling is essential for the survival of breast cancer stem cells. Int J Cancer. 2020 03 15; 146(6):1674-1685. Chan YT, Lai AC, Lin RJ, Wang YH, Wang YT, Chang WW, Wu HY, Lin YJ, Chang WY, Wu JC, Yu JC, Chen YJ, Yu AL. PMID: 31340060.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    5. Sialylation of vasorin by ST3Gal1 facilitates TGF-ß1-mediated tumor angiogenesis and progression. Int J Cancer. 2019 04 15; 144(8):1996-2007. Yeo HL, Fan TC, Lin RJ, Yu JC, Liao GS, Chen ES, Ho MY, Lin WD, Chen K, Chen CH, Hung JT, Wu JC, Chang NC, Chang MD, Yu J, Yu AL. PMID: 30252131.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    6. Reciprocal feedback regulation of ST3GAL1 and GFRA1 signaling in breast cancer cells. Cancer Lett. 2018 10 10; 434:184-195. Fan TC, Yeo HL, Hsu HM, Yu JC, Ho MY, Lin WD, Chang NC, Yu J, Yu AL. PMID: 30040982.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    7. Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931. Front Immunol. 2018; 9:1641. Ozkaynak MF, Gilman AL, London WB, Naranjo A, Diccianni MB, Tenney SC, Smith M, Messer KS, Seeger R, Reynolds CP, Smith LM, Shulkin BL, Parisi M, Maris JM, Park JR, Sondel PM, Yu AL. PMID: 30046297.
      View in: PubMed   Mentions: 3     Fields:    
    8. A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931. Front Immunol. 2018; 9:1355. Ozkaynak MF, Gilman AL, London WB, Naranjo A, Diccianni MB, Tenney SC, Smith M, Messer KS, Seeger R, Reynolds CP, Smith LM, Shulkin BL, Parisi M, Maris JM, Park JR, Sondel PM, Yu AL. PMID: 29967609.
      View in: PubMed   Mentions: 14     Fields:    
    9. Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group. Clin Cancer Res. 2018 01 01; 24(1):189-196. Erbe AK, Wang W, Carmichael L, Kim K, Mendonça EA, Song Y, Hess D, Reville PK, London WB, Naranjo A, Hank JA, Diccianni MB, Reisfeld RA, Gillies SD, Matthay KK, Cohn SL, Hogarty MD, Maris JM, Park JR, Ozkaynak MF, Gilman AL, Yu AL, Sondel PM. PMID: 28972044.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    10. High expression FUT1 and B3GALT5 is an independent predictor of postoperative recurrence and survival in hepatocellular carcinoma. Sci Rep. 2017 09 07; 7(1):10750. Kuo HH, Lin RJ, Hung JT, Hsieh CB, Hung TH, Lo FY, Ho MY, Yeh CT, Huang YL, Yu J, Yu AL. PMID: 28883415.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    11. HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy. Front Immunol. 2017; 8:675. Erbe AK, Wang W, Reville PK, Carmichael L, Kim K, Mendonca EA, Song Y, Hank JA, London WB, Naranjo A, Hong F, Hogarty MD, Maris JM, Park JR, Ozkaynak MF, Miller JS, Gilman AL, Kahl B, Yu AL, Sondel PM. PMID: 28659916.
      View in: PubMed   Mentions: 7     Fields:    
    12. Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial. Lancet Oncol. 2017 07; 18(7):946-957. Mody R, Naranjo A, Van Ryn C, Yu AL, London WB, Shulkin BL, Parisi MT, Servaes SE, Diccianni MB, Sondel PM, Bender JG, Maris JM, Park JR, Bagatell R. PMID: 28549783.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    13. Englerin A induces an acute inflammatory response and reveals lipid metabolism and ER stress as targetable vulnerabilities in renal cell carcinoma. PLoS One. 2017; 12(3):e0172632. Batova A, Altomare D, Creek KE, Naviaux RK, Wang L, Li K, Green E, Williams R, Naviaux JC, Diccianni M, Yu AL. PMID: 28296891.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    14. Evidence for a common evolutionary rate in metazoan transcriptional networks. Elife. 2015 Dec 18; 4. Carvunis AR, Wang T, Skola D, Yu A, Chen J, Kreisberg JF, Ideker T. PMID: 26682651.
      View in: PubMed   Mentions: 13     Fields:    Translation:Animals
    15. Erratum: renal cancer-selective Englerin A induces multiple mechanisms of cell death and autophagy. J Exp Clin Cancer Res. 2014 Dec 05; 33:95. Williams RT, Yu AL, Diccianni MB, Theodorakis EA, Batova A. PMID: 25480670.
      View in: PubMed   Mentions:    Fields:    
    16. Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma. Br J Pharmacol. 2014 Dec; 171(23):5330-44. Sonawane P, Cho HE, Tagde A, Verlekar D, Yu AL, Reynolds CP, Kang MH. PMID: 25039756.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    17. Globo-H ceramide shed from cancer cells triggers translin-associated factor X-dependent angiogenesis. Cancer Res. 2014 Dec 01; 74(23):6856-66. Cheng JY, Wang SH, Lin J, Tsai YC, Yu J, Wu JC, Hung JT, Lin JJ, Wu YY, Yeh KT, Yu AL. PMID: 25281721.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    18. The prognostic significance of RUNX2 and miR-10a/10b and their inter-relationship in breast cancer. J Transl Med. 2014 Sep 30; 12:257. Chang CH, Fan TC, Yu JC, Liao GS, Lin YC, Shih AC, Li WH, Yu AL. PMID: 25266482.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    19. A novel oncogenic role of inositol phosphatase SHIP2 in ER-negative breast cancer stem cells: involvement of JNK/vimentin activation. Stem Cells. 2014 Aug; 32(8):2048-60. Fu CH, Lin RJ, Yu J, Chang WW, Liao GS, Chang WY, Tseng LM, Tsai YF, Yu JC, Yu AL. PMID: 24802135.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    20. High expression of CAI2, a 9p21-embedded long noncoding RNA, contributes to advanced-stage neuroblastoma. Cancer Res. 2014 Jul 15; 74(14):3753-63. Barnhill LM, Williams RT, Cohen O, Kim Y, Batova A, Mielke JA, Messer K, Pu M, Bao L, Yu AL, Diccianni MB. PMID: 25028366.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    21. Potent adjuvant effects of novel NKT stimulatory glycolipids on hemagglutinin based DNA vaccine for H5N1 influenza virus. Antiviral Res. 2014 Jul; 107:110-8. Hung JT, Tsai YC, Lin WD, Jan JT, Lin KH, Huang JR, Cheng JY, Chen MW, Wong CH, Yu AL. PMID: 24786174.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    22. Chimeric antibody c.8B6 to O-acetyl-GD2 mediates the same efficient anti-neuroblastoma effects as therapeutic ch14.18 antibody to GD2 without antibody induced allodynia. PLoS One. 2014; 9(2):e87210. Terme M, Dorvillius M, Cochonneau D, Chaumette T, Xiao W, Diccianni MB, Barbet J, Yu AL, Paris F, Sorkin LS, Birklé S. PMID: 24520328.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    23. Chimeras of p14ARF and p16: functional hybrids with the ability to arrest growth. PLoS One. 2014; 9(2):e88219. Williams RT, Barnhill LM, Kuo HH, Lin WD, Batova A, Yu AL, Diccianni MB. PMID: 24505435.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    24. Absence of MGST1 mRNA and protein expression in human neuroblastoma cell lines and primary tissue. Free Radic Biol Med. 2014 Apr; 69:167-71. Kelner MJ, Diccianni MB, Yu AL, Rutherford MR, Estes LA, Morgenstern R. PMID: 24486338.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    25. Renal cancer-selective Englerin A induces multiple mechanisms of cell death and autophagy. J Exp Clin Cancer Res. 2013 Aug 20; 32:57. Williams RT, Yu AL, Diccianni MB, Theodorakis EA, Batova A. PMID: 23958461.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    26. Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial. Lancet Oncol. 2013 Sep; 14(10):999-1008. Kreissman SG, Seeger RC, Matthay KK, London WB, Sposto R, Grupp SA, Haas-Kogan DA, Laquaglia MP, Yu AL, Diller L, Buxton A, Park JR, Cohn SL, Maris JM, Reynolds CP, Villablanca JG. PMID: 23890779.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansCTClinical Trials
    27. Concordant and discordant regulation of target genes by miR-31 and its isoforms. PLoS One. 2013; 8(3):e58169. Chan YT, Lin YC, Lin RJ, Kuo HH, Thang WC, Chiu KP, Yu AL. PMID: 23472152.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    28. Ethical issues for control-arm patients after revelation of benefits of experimental therapy: a framework modeled in neuroblastoma. J Clin Oncol. 2013 Feb 10; 31(5):641-6. Unguru Y, Joffe S, Fernandez CV, Yu AL. PMID: 23295797.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Synthesis and evaluation of acyl-chain- and galactose-6''-modified analogues of a-GalCer for NKT cell activation. Chembiochem. 2012 Jul 23; 13(11):1689-97. Hsieh MH, Hung JT, Liw YW, Lu YJ, Wong CH, Yu AL, Liang PH. PMID: 22730199.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    30. Promising therapeutic targets in neuroblastoma. Clin Cancer Res. 2012 May 15; 18(10):2740-53. Matthay KK, George RE, Yu AL. PMID: 22589483.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    31. Cluvenone induces apoptosis via a direct target in mitochondria: a possible mechanism to circumvent chemo-resistance? Invest New Drugs. 2012 Oct; 30(5):1841-8. Guizzunti G, Theodorakis EA, Yu AL, Zurzolo C, Batova A. PMID: 21898184.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    32. Switching of the core structures of glycosphingolipids from globo- and lacto- to ganglio-series upon human embryonic stem cell differentiation. Proc Natl Acad Sci U S A. 2010 Dec 28; 107(52):22564-9. Liang YJ, Kuo HH, Lin CH, Chen YY, Yang BC, Cheng YY, Yu AL, Khoo KH, Yu J. PMID: 21149694.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    33. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med. 2010 Sep 30; 363(14):1324-34. Yu AL, Gilman AL, Ozkaynak MF, London WB, Kreissman SG, Chen HX, Smith M, Anderson B, Villablanca JG, Matthay KK, Shimada H, Grupp SA, Seeger R, Reynolds CP, Buxton A, Reisfeld RA, Gillies SD, Cohn SL, Maris JM, Sondel PM. PMID: 20879881.
      View in: PubMed   Mentions: 440     Fields:    Translation:Humans
    34. The synthetic caged garcinia xanthone cluvenone induces cell stress and apoptosis and has immune modulatory activity. . 2010 Nov; 9(11):2869-78. Batova A, Altomare D, Chantarasriwong O, Ohlsen KL, Creek KE, Lin YC, Messersmith A, Yu AL, Yu J, Theodorakis EA. PMID: 20881270.
      View in: PubMed   Mentions:
    35. microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma. Cancer Res. 2010 Oct 15; 70(20):7841-50. Lin RJ, Lin YC, Chen J, Kuo HH, Chen YY, Diccianni MB, London WB, Chang CH, Yu AL. PMID: 20805302.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCells
    36. miR-149* induces apoptosis by inhibiting Akt1 and E2F1 in human cancer cells. Mol Carcinog. 2010 Aug; 49(8):719-27. Lin RJ, Lin YC, Yu AL. PMID: 20623644.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    37. Immunomodulatory and adjuvant activities of a polysaccharide extract of Ganoderma lucidum in vivo and in vitro. Vaccine. 2010 Jul 12; 28(31):4945-54. Lai CY, Hung JT, Lin HH, Yu AL, Chen SH, Tsai YC, Shao LE, Yang WB, Yu J. PMID: 20653103.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    38. TGF-{beta}2 induces senescence-associated changes in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2010 Nov; 51(11):5718-23. Yu AL, Birke K, Moriniere J, Welge-Lüssen U. PMID: 20554622.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    39. Anti-GD(2) with an FC point mutation reduces complement fixation and decreases antibody-induced allodynia. Pain. 2010 Apr; 149(1):135-42. Sorkin LS, Otto M, Baldwin WM, Vail E, Gillies SD, Handgretinger R, Barfield RC, Ming Yu H, Yu AL. PMID: 20171010.
      View in: PubMed   Mentions: 50     Fields:    Translation:Animals
    40. A phase II study of Campath-1H in children with relapsed or refractory acute lymphoblastic leukemia: a Children's Oncology Group report. Pediatr Blood Cancer. 2009 Dec; 53(6):978-83. Angiolillo AL, Yu AL, Reaman G, Ingle AM, Secola R, Adamson PC. PMID: 19637330.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    41. Inactivation of SHIP1 in T-cell acute lymphoblastic leukemia due to mutation and extensive alternative splicing. Leuk Res. 2009 Nov; 33(11):1562-6. Lo TC, Barnhill LM, Kim Y, Nakae EA, Yu AL, Diccianni MB. PMID: 19473701.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    42. BO-0742, a derivative of AHMA and N-mustard, has selective toxicity to drug sensitive and drug resistant leukemia cells and solid tumors. Cancer Lett. 2009 Apr 18; 276(2):204-11. Lee CH, Chou TC, Su TL, Yu J, Shao LE, Yu AL. PMID: 19108949.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    43. Phase I study of ch14.18 with granulocyte-macrophage colony-stimulating factor and interleukin-2 in children with neuroblastoma after autologous bone marrow transplantation or stem-cell rescue: a report from the Children's Oncology Group. J Clin Oncol. 2009 Jan 01; 27(1):85-91. Gilman AL, Ozkaynak MF, Matthay KK, Krailo M, Yu AL, Gan J, Sternberg A, Hank JA, Seeger R, Reaman GH, Sondel PM. PMID: 19047298.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCTClinical Trials
    44. Nonparametric estimation of LOH using Affymetrix SNP genotyping arrays for unpaired samples. J Hum Genet. 2008; 53(11-12):983-990. Huggins R, Li LH, Lin YC, Yu AL, Yang HC. PMID: 18989737.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    45. Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis. Proc Natl Acad Sci U S A. 2008 Aug 19; 105(33):11667-72. Chang WW, Lee CH, Lee P, Lin J, Hsu CW, Hung JT, Lin JJ, Yu JC, Shao LE, Yu J, Wong CH, Yu AL. PMID: 18685093.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansAnimalsCells
    46. c-Myb is an evolutionary conserved miR-150 target and miR-150/c-Myb interaction is important for embryonic development. Mol Biol Evol. 2008 Oct; 25(10):2189-98. Lin YC, Kuo MW, Yu J, Kuo HH, Lin RJ, Lo WL, Yu AL. PMID: 18667440.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    47. MPDA: microarray pooled DNA analyzer. BMC Bioinformatics. 2008 Apr 15; 9:196. Yang HC, Huang MC, Li LH, Lin CH, Yu AL, Diccianni MB, Wu JY, Chen YT, Fann CS. PMID: 18412951.
      View in: PubMed   Mentions: 10     Fields:    Translation:Cells
    48. Human TRIM71 and its nematode homologue are targets of let-7 microRNA and its zebrafish orthologue is essential for development. Mol Biol Evol. 2007 Nov; 24(11):2525-34. Lin YC, Hsieh LC, Kuo MW, Yu J, Kuo HH, Lo WL, Lin RJ, Yu AL, Li WH. PMID: 17890240.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimalsCells
    49. Synthesis and evaluation of caged Garcinia xanthones. Org Biomol Chem. 2007 Feb 07; 5(3):494-500. Batova A, Lam T, Wascholowski V, Yu AL, Giannis A, Theodorakis EA. PMID: 17252132.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    50. Identification of pulmonary Oct-4+ stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in vitro. Proc Natl Acad Sci U S A. 2006 Jun 20; 103(25):9530-5. Ling TY, Kuo MD, Li CL, Yu AL, Huang YH, Wu TJ, Lin YC, Chen SH, Yu J. PMID: 16772384.
      View in: PubMed   Mentions: 52     Fields:    Translation:AnimalsCells
    51. EFA (9-beta-D-erythrofuranosyladenine) is an effective salvage agent for methylthioadenosine phosphorylase-selective therapy of T-cell acute lymphoblastic leukemia with L-alanosine. Blood. 2006 Feb 01; 107(3):898-903. Batova A, Cottam H, Yu J, Diccianni MB, Carrera CJ, Yu AL. PMID: 16234352.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    52. Temozolomide and radiation for aggressive pediatric central nervous system malignancies. J Pediatr Hematol Oncol. 2005 May; 27(5):254-8. Loh KC, Willert J, Meltzer H, Roberts W, Kerlin B, Kadota R, Levy M, White G, Geddis A, Schiff D, Martin L, Yu A, Kung F, Spear MA. PMID: 15891559.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    53. Expression profiles and clinical relationships of ID2, CDKN1B, and CDKN2A in primary neuroblastoma. Genes Chromosomes Cancer. 2004 Dec; 41(4):297-308. Gebauer S, Yu AL, Omura-Minamisawa M, Batova A, Diccianni MB. PMID: 15390183.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    54. 3-amino thioacridone inhibits DNA synthesis and induce DNA damage in T-cell acute lymphoblastic leukemia (T-ALL) in a p16-dependent manner. J Exp Ther Oncol. 2004 Oct; 4(3):223-37. Diccianni MB, Yu J, Meppelink G, de Vries M, Shao L, Gebauer S, Shih H, Roberts W, Kilcoin NP, Pullen J, Carson DA, Yu AL. PMID: 15724842.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    55. The role of methionine in ethylmalonic encephalopathy with petechiae. Arch Neurol. 2004 Apr; 61(4):570-4. McGowan KA, Nyhan WL, Barshop BA, Naviaux RK, Yu A, Haas RH, Townsend JJ. PMID: 15096407.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    56. Testing of new agents in childhood cancer preclinical models: meeting summary. Clin Cancer Res. 2002 Dec; 8(12):3646-57. Houghton PJ, Adamson PC, Blaney S, Fine HA, Gorlick R, Haber M, Helman L, Hirschfeld S, Hollingshead MG, Israel MA, Lock RB, Maris JM, Merlino G, Patterson W, Reynolds CP, Shannon K, Yu A, Yu J, Smith MA. PMID: 12473573.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimals
    57. The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines. Blood. 2002 Nov 01; 100(9):3319-24. Batova A, Shao LE, Diccianni MB, Yu AL, Tanaka T, Rephaeli A, Nudelman A, Yu J. PMID: 12384433.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    58. Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study. J Clin Oncol. 2002 May 01; 20(9):2284-92. Kletzel M, Katzenstein HM, Haut PR, Yu AL, Morgan E, Reynolds M, Geissler G, Marymount MH, Liu D, Kalapurakal JA, Shore RM, Bardo DM, Schmoldt J, Rademaker AW, Cohn SL. PMID: 11980999.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    59. Inhibition of Bcl-xL expression sensitizes T-cell acute lymphoblastic leukemia cells to chemotherapeutic drugs. Leuk Res. 2002 Mar; 26(3):311-6. Broome HE, Yu AL, Diccianni M, Camitta BM, Monia BP, Dean NM. PMID: 11792421.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    Alice's Networks
    Concepts (418)
    Derived automatically from this person's publications.
    _
    Co-Authors (24)
    People in Profiles who have published with this person.
    _
    Similar People (59)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _